Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2007
11/15/2007US20070264258 Sialoadhesin factor-2 antibodies
11/15/2007US20070264256 polynucleotide sequence of a NTHi, polypeptides encoded by it and antibodies that bind to the polypeptide; detecting NTHi bacteria in a biological sample by contacting a polynucleotide to detect hybridization of the polynucleotide
11/15/2007US20070264255 Antibodies to TGF-beta
11/15/2007US20070264253 Human Anti-Epidermal Growth Factor Receptor Antibody
11/15/2007US20070264237 Use of Il-18 Binding Protein in Inflammations
11/15/2007US20070264197 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
11/15/2007CA2652599A1 Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
11/15/2007CA2652247A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007CA2651723A1 A novel group of esterases for the enantioselective production of fine and speciality chemicals
11/15/2007CA2651565A1 Antagonistic anti-human cd40 monoclonal antibody
11/15/2007CA2651348A1 Rage fusion proteins, formulations, and methods of use thereof
11/15/2007CA2651117A1 Method for producing stable mammalian cell lines producing high levels of recombinant proteins
11/15/2007CA2650963A1 St2 as a cardiovascular disease marker for high-bmi or impaired renal function patients
11/15/2007CA2650953A1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody
11/15/2007CA2650718A1 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
11/15/2007CA2649962A1 Hcv coreceptor and methods of use thereof
11/15/2007CA2649872A1 Trail receptor-binding agents and uses of the same
11/15/2007CA2648947A1 Therapy targeting cathepsin s
11/15/2007CA2648484A1 Antibody-targeted cytokines for therapy
11/15/2007CA2638785A1 Anti-ephb4 antibodies and methods using same
11/14/2007EP1854885A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854881A1 METHODS OF IDENTIFYING PURKINJE CELLS USING THE Corl2 GENE AS A TARGET
11/14/2007EP1854811A1 Assay method for human orotate phosphoribosyltransferase protein
11/14/2007EP1854810A1 Deimmunized antagonistic anti-human CD40 monoclonal antibody from the ch5D12 antibody
11/14/2007EP1854808A2 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/14/2007EP1854481A2 Cerebral stroke/cerebral edema preventive or remedy containing IL-8 binding inhibitor as active ingredient
11/14/2007EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/14/2007EP1853707A2 Uses of il-23 antagonists in the treatment of diabetes mellitus
11/14/2007EP1853631A2 Fc-fusion constructs binding to phosphatidylserine and their therapeutic use
11/14/2007EP1853630A1 Methods of optimizing antibody variable region binding affinity
11/14/2007EP1853629A2 Human ring specific bnp antibodies
11/14/2007EP1853313A2 Humanized l243 antibodies
11/14/2007EP1853312A2 Methods and compositions for modulating tweak and fn14 activity
11/14/2007EP1853310A2 Anti a beta antibody formulation
11/14/2007EP1853108A2 Tissue specific expression of antibodies in chickens
11/14/2007EP1700120A4 Marker for neuromyelitis optica
11/14/2007EP1485473B1 Production of ugppase
11/14/2007EP1468022B1 Novel monoclonal antibody and nematode larval antigens
11/14/2007EP1411064B1 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
11/14/2007EP1387698B1 Method of preventing cell death using antibodies to neural thread proteins
11/14/2007EP1354034B1 Transgenic transchromosomal rodents for making human antibodies
11/14/2007EP1322666B1 Hiv peptides from tat,rev and wef conserved regions and their application as e.gvacine compnents
11/14/2007EP1254239B1 Mammalian secreted group iii phospholipase a2
11/14/2007EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1190259B1 Diagnostic assay for human matrix gla-protein and its use as a biomarker
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1114156B1 Mammalian transforming growth factor beta - 9 (ztgfss9)
11/14/2007EP1092017B1 Novel gaba-b receptor
11/14/2007EP1007718B1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0756628B1 Morphogenic protein-specific cell surface receptors and uses therefor
11/14/2007EP0641218B2 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
11/14/2007CN101072797A Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/14/2007CN101072796A Monoclonal and polyclonal antibodies to equine hemoglobin and apparatus and methods using the antibodies and/or peroxidase reactions in the identification and localization of ulcers in equines
11/14/2007CN101072795A Human monoclonal antibodies to influenza m2 protein and methods of making and using same
11/14/2007CN101072794A Method for affinity purification
11/14/2007CN101072793A Il-7 variants with reduced immunogenicity
11/14/2007CN101072587A Anti-cd154 antibodies
11/14/2007CN101072580A Antibody production method
11/14/2007CN101070541A Gene engineering antibody of resisting chicken newcastle disease virus
11/14/2007CN101070540A New dendritic cell co-stimulatory molecules
11/14/2007CN101070346A Method for preparing double-function antibody
11/14/2007CN101070345A Anti-prostate-specific-antigen PSA monoclone antibody and its use
11/14/2007CN101070344A G-csf receptor agonist antibodies and screening method therefor
11/14/2007CN100348616C Bt CrylA antibody, and its preparing method and special antigen and use
11/14/2007CN100348615C Gene of restraining activation NF-kB and NFAT, and coded polypeptide
11/13/2007US7294753 Method for preparing anti-MIF antibodies
11/13/2007US7294712 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
11/13/2007US7294710 High-affinity choline transporter
11/13/2007US7294705 Anti-PRO3580 antibodies
11/13/2007US7294704 Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
11/13/2007US7294703 Vectors with DNA encoding pro polypeptides
11/13/2007US7294702 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2007US7294701 Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
11/13/2007US7294700 Anti-PRO846 antibodies
11/13/2007US7294698 An isolated Archipelin polypeptide
11/13/2007US7294693 Pro4428 Polypeptides
11/13/2007US7294692 Vectors with DNA encoding pro polypeptides
11/13/2007US7294495 PR03580 polypeptides
11/13/2007US7294483 Culturing E. coli cells comprising a nucleic acid encoding the polypeptide in a culture medium while feeding to the culture medium a transportable organophosphate that is a sugar phosphate or a glycerophosphate, such that the nucleic acid is expressed, recovering the polypeptide from the cells
11/13/2007US7294473 Methods of identifying substances that interact with JTT-1 protein
11/13/2007US7294459 Cell regulatory genes, encoded products, and uses related thereto
11/13/2007US7294336 Stabilized liquid anti-RSV antibody formulations
11/13/2007CA2333469C Myotilin, an actin-organizing protein
11/13/2007CA2006813C Purified ciliary neurotrophic factor
11/09/2007CA2589295A1 Characterization of c19orf10, a novel synovial protein
11/09/2007CA2547136A1 Novel strain of pseudomonas aeruginosa and related therapeutic components
11/08/2007WO2007127506A2 Anti-ephrinb2 antibodies and methods using same
11/08/2007WO2007127476A2 Monoclonal antibodies specific for pancreatic endocrine, exocrine or ductal cell
11/08/2007WO2007126799A2 Compositions and methods of use for antibodies of c-met
11/08/2007WO2007126798A2 Regulated expression of recombinant proteins from adeno-associated viral vectors
11/08/2007WO2007126787A2 Reagents and methods for cancer treatment and prevention
11/08/2007WO2007126655A1 Eggs having increased antibody titer and methods for making same
11/08/2007WO2007126439A2 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
11/08/2007WO2007126160A1 Prostasin partial peptide and anti-prostasin antibody
11/08/2007WO2007126155A1 Anti-2-o-desulfated acharan sulfate antibody and its application
11/08/2007WO2007126152A1 Anti-acharan sulfate antibody and its application
11/08/2007WO2007125940A1 Polypeptide derived from adult cat flea
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 1494